Pharma News, 2015
Lupin gets FDA nod for generic Femhrt tablets
Drug major Lupin has received US health regulator’s approval to market Fyavolv tablets, used to treat postmenopausal osteoporosis, in the American market.
Eagle Pharmaceuticals Announces FDA Approval of Docetaxel Injection, Non-Alcohol Formula
WOODCLIFF LAKE, N.
European Medicines Agency Accepts Fanaptum® (iloperidone) Marketing Authorization Application for the Treatment of Schizophrenia in Adults
Vanda Pharmaceuticals Inc.
Pollution may be a cause for antibiotic resistance
According to researchers, pollution may be a cause for antibiotic resistance and why the bacteria are becoming so resilient to medication.
Indian pharmaceutical industry likely to touch USD 55 bln by 2020: study
Indian pharmaceutical industry is expected to touch USD 55 billion by 2020 as against the current size of USD 18 billion but the exports may slow down to grow at a CAGR of 7.
Common anesthetic could be helpful in treating depression induced by diet
Researchers from Yale University have reported that , an anesthetic can reverse symptoms similar to depression in rats that were fed high-fat diet similar to the way it addresses synaptic damage from ...
New drug may slow down Alzheimer's: study
A drug that boosts activity in the brain's "garbage disposal" system may decrease levels of toxic proteins linked with Alzheimer's and other neurodegenerative diseases, scientists ha...
ZURAMPIC® (lesinurad) approved by US FDA for patients with gout
AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved ZURAMPIC® (lesinurad) 200mg tablets in combination with a xanthine oxidase inhibitor (XOI...
Overseas M&A deals at 5-year high in pharma, healthcar
Overseas mergers and acquisitions (M&As) led deal activity in the pharmaceuticals and healthcare sector in 2015, their value hitting a five-year high.
Hillary Clinton Reveals Plan To Battle Alzheimer's Disease
NEW YORK (Reuters) - Democratic presidential candidate Hillary Clinton on Tuesday announced a slate of proposals to battle Alzheimer's disease and seek a cure by 2025, including an increas...